Variant report
Variant | nsv975615 |
---|---|
Chromosome Location | chr12:11063847-11076282 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:17)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:17 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr12:11071698-11071803 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr12:11072040-11072190 | Caco-2 | colon: | n/a | n/a |
3 | FOXA1 | chr12:11071456-11071958 | HepG2 | liver: | n/a | chr12:11071682-11071697 chr12:11071684-11071696 chr12:11071534-11071546 chr12:11071715-11071730 |
4 | FOXA1 | chr12:11071500-11071845 | T-47D | breast: | n/a | chr12:11071682-11071697 chr12:11071684-11071696 chr12:11071534-11071546 chr12:11071715-11071730 |
5 | FOXA2 | chr12:11074233-11074450 | HepG2 | liver: | n/a | n/a |
6 | FOXA2 | chr12:11071411-11072008 | A549 | lung: | n/a | chr12:11071684-11071696 chr12:11071534-11071546 |
7 | JUN | chr12:11069650-11069864 | HepG2 | liver: | n/a | chr12:11069757-11069770 |
8 | KAP1 | chr12:11073002-11073318 | K562 | blood: | n/a | n/a |
9 | MAFK | chr12:11075107-11075120 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | POLR2A | chr12:11072181-11072239 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | POLR2A | chr12:11072132-11072389 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | POLR2A | chr12:11067514-11067692 | K562 | blood: | n/a | n/a |
13 | POLR2A | chr12:11066491-11066600 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | RFX5 | chr12:11066359-11066365 | K562 | blood: | n/a | n/a |
15 | STAT3 | chr12:11071629-11071813 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | STAT3 | chr12:11068395-11068587 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | TAL1 | chr12:11070124-11070158 | K562 | blood: | n/a | n/a |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:11062779..11064988-chr12:11068895..11070705,2 | K562 | blood: | |
2 | chr12:11065171..11067807-chr12:11068288..11070979,2 | K562 | blood: | |
3 | chr12:11060198..11062060-chr12:11071921..11074796,2 | MCF-7 | breast: | |
4 | chr12:11044254..11045058-chr12:11074291..11074831,2 | MCF-7 | breast: | |
5 | chr12:11065171..11067807-chr12:11068288..11070979,2 | K562 | blood: | |
6 | chr12:10994716..10997527-chr12:11072038..11073829,2 | K562 | blood: | |
7 | chr12:11062779..11064988-chr12:11068895..11070705,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
TAS2R13 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533022326 | chr12:11063857-11063858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546610079 | chr12:11063885-11063886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375525482 | chr12:11063923-11063924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566639678 | chr12:11063940-11063941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376564744 | chr12:11063957-11063958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182332631 | chr12:11063972-11063973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7299223 | chr12:11063996-11063997 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs568934274 | chr12:11064072-11064073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537943495 | chr12:11064082-11064083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531425135 | chr12:11064087-11064088 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577730247 | chr12:11064213-11064214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540110764 | chr12:11064226-11064227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553435117 | chr12:11064298-11064299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573374985 | chr12:11064303-11064304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542016322 | chr12:11064397-11064398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541992961 | chr12:11064401-11064402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562309694 | chr12:11064406-11064407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575303800 | chr12:11064457-11064458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562241169 | chr12:11064477-11064478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544311790 | chr12:11064504-11064505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150517817 | chr12:11064513-11064514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559915277 | chr12:11064538-11064539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533181785 | chr12:11064570-11064571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368911375 | chr12:11064583-11064584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186899349 | chr12:11064599-11064600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560229843 | chr12:11064604-11064605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529200307 | chr12:11064628-11064629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139508904 | chr12:11064647-11064648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs527911426 | chr12:11064659-11064660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547984451 | chr12:11064672-11064673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs72656639 | chr12:11064690-11064691 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs149696102 | chr12:11064827-11064828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191956578 | chr12:11064832-11064833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549726458 | chr12:11064895-11064896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs147501376 | chr12:11064908-11064909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs542345506 | chr12:11064937-11064938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs140085016 | chr12:11064944-11064945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535553134 | chr12:11064954-11064955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs117412092 | chr12:11064983-11064984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567898780 | chr12:11065013-11065014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536165343 | chr12:11065016-11065017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555503931 | chr12:11065143-11065144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113174412 | chr12:11065178-11065179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533715039 | chr12:11065203-11065204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575466027 | chr12:11065246-11065247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553955268 | chr12:11065266-11065267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7956586 | chr12:11065367-11065368 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs181511548 | chr12:11065381-11065382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577607797 | chr12:11065406-11065407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556192206 | chr12:11065407-11065408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 17690704 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Prostate cancer | 19156837 | CNVD |
Emphysema | 19352772 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16461572 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Melanoma | 20877625 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:11033800-11101600 | Weak transcription | Ovary | ovary |
2 | chr12:11039200-11070200 | Weak transcription | Left Ventricle | heart |
3 | chr12:11054400-11084800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr12:11058000-11081200 | Weak transcription | Primary T cells from cord blood | blood |
5 | chr12:11058200-11081800 | Weak transcription | Aorta | Aorta |
6 | chr12:11060600-11068200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
7 | chr12:11061600-11079800 | Weak transcription | HepG2 | liver |
8 | chr12:11063400-11066200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
9 | chr12:11064000-11064200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr12:11064000-11067000 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
11 | chr12:11064200-11065600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr12:11065200-11067600 | Weak transcription | Placenta | Placenta |
13 | chr12:11065200-11093000 | Weak transcription | Primary hematopoietic stem cells | blood |
14 | chr12:11066200-11066800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
15 | chr12:11069000-11069200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr12:11069200-11094800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr12:11070000-11070200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
18 | chr12:11070200-11070800 | Strong transcription | Left Ventricle | heart |
19 | chr12:11070400-11070600 | Enhancers | Gastric | stomach |
20 | chr12:11070400-11070800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
21 | chr12:11070600-11079600 | Weak transcription | Gastric | stomach |
22 | chr12:11070800-11079200 | Weak transcription | Left Ventricle | heart |
23 | chr12:11071200-11071400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
24 | chr12:11071400-11079200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
25 | chr12:11072000-11072200 | Enhancers | A549 | lung |
26 | chr12:11072200-11092800 | Weak transcription | A549 | lung |